Xylem Inc. (XYL) Earnings Call Transcripts

48 earnings calls from February 2020 to July 28, 2026

NYSE US Industrials Machinery

Xylem Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of fiscal year 2026, Xylem Inc. reported revenue of approximately $2.3 billion, reflecting a 1% increase year-over-year, which was in line with expectations. Earnings per share (EPS) reached a record $1.46, a 16% increase compared to the previous year. Management narrowed its full-year revenue guidance to approximately $9.2 billion, indicating a growth rate of about 2%, while raising EPS guidance to a range of $5.55 to $5.70, signaling confidence in operational momentum despite challenges in certain segments, particularly in China and electric metering.

Reported metrics

MetricValueContext
Revenue $2.3B (inline) vs $2.3B est, +1% YoY
EPS $1.46 (beat) beat by $0.12
EBITDA Margin 23.3% (positive) up 150 bps YoY
Backlog $5.3B (positive) healthy demand with book-to-bill above 1
Organic Revenue Growth Guidance 2% to 3% (negative) narrowed from 2% to 4%
Full Year Revenue Guidance $9.2B (neutral) approximately 2% growth

Guidance from management

Management expects third quarter revenue growth to be flat on a reported basis and up roughly 3% organically, with an EBITDA margin of approximately 23.5% to 24%. They raised EPS guidance to a range of $5.55 to $5.70 for the full year.

What management said

I think positive overall. I mean, even with the 80/20 actions and some of the projects where we've increased price, we've had a very strong win rate. So I think the treatment market here in the U.S. has been really positive for that business. And I think we expect that to continue in the second half. A lot of the challenges there, again, relative to China. Different decisions we've made on our bidding strategy around...
— Matthew Pine, Q2 FY2026 earnings call
I mean it's something we review really monthly in our leadership meeting. I don't think there's anything pressing right now that we already haven't taken action on. Obviously, we look at rare earth, and we've got most of our businesses about a year of supply we pulled in from a safety stock perspective. Obviously, we've made some investments, and I might have highlighted this on a prior call on chips. -- wafers looki...
— Matthew Pine, Q2 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the significant decline in revenue from China and the impact of electric metering project delays on overall performance. There were questions about the sustainability of growth in the Applied Water segment and how the company plans to navigate the challenges in the electric metering market.

Main topics on the call

Read the full Xylem Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Xylem Inc.

Xylem Inc. (XYL) is a publicly listed company in the Machinery industry, within the Industrials sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 48 calls on record spanning February 6, 2020 to July 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 48 Xylem Inc. earnings call transcripts on record, spanning February 6, 2020 to July 28, 2026. Based on this history, Xylem Inc. reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
XYL
Exchange
NYSE
Country
US
Sector
Industrials
Industry
Machinery
Calls on record
48
First call
February 6, 2020
Most recent
July 28, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 28, 2026 Read transcript
Q1 FY2026 Apr 28, 2026 Read transcript
Q4 FY2025 Feb 10, 2026 Read transcript
Q3 FY2025 Oct 28, 2025 Read transcript
Q2 FY2025 Jul 31, 2025 Read transcript
Q1 FY2025 Apr 29, 2025 Read transcript
Q4 FY2024 Feb 4, 2025 Read transcript
Q3 FY2024 Oct 31, 2024 Read transcript
Q2 FY2024 Jul 30, 2024 Read transcript
Company Conference Presentations Jun 4, 2024 Read transcript
Analyst/Investor Day May 30, 2024 Read transcript
Q1 FY2024 May 2, 2024 Read transcript
Company Conference Presentations Feb 20, 2024 Read transcript
Q4 FY2023 Feb 6, 2024 Read transcript
Company Conference Presentations Nov 7, 2023 Read transcript
Q3 FY2023 Oct 31, 2023 Read transcript
Company Conference Presentations Sep 27, 2023 Read transcript
Company Conference Presentations Sep 13, 2023 Read transcript
Company Conference Presentations Sep 6, 2023 Read transcript
Q2 FY2023 Aug 2, 2023 Read transcript
Company Conference Presentations Jun 9, 2023 Read transcript
Company Conference Presentations Jun 7, 2023 Read transcript
Q1 FY2023 May 4, 2023 Read transcript
Q4 FY2022 Feb 7, 2023 Read transcript
M&A Calls Jan 23, 2023 Read transcript
Q3 FY2022 Nov 1, 2022 Read transcript
Company Conference Presentations Sep 16, 2022 Read transcript
Q2 FY2022 Aug 2, 2022 Read transcript
Q1 FY2022 May 4, 2022 Read transcript
Company Conference Presentations Feb 24, 2022 Read transcript
Q4 FY2021 Feb 3, 2022 Read transcript
Q3 FY2021 Nov 2, 2021 Read transcript
Analyst/Investor Day Sep 30, 2021 Read transcript
Company Conference Presentations Sep 15, 2021 Read transcript
Company Conference Presentations Sep 10, 2021 Read transcript
Q2 FY2021 Aug 3, 2021 Read transcript
Shareholder/Analyst Calls May 12, 2021 Read transcript
Q1 FY2021 May 4, 2021 Read transcript
Company Conference Presentations Feb 25, 2021 Read transcript
Q4 FY2020 Feb 4, 2021 Read transcript
Q3 FY2020 Oct 29, 2020 Read transcript
Company Conference Presentations Sep 29, 2020 Read transcript
Company Conference Presentations Sep 15, 2020 Read transcript
Q2 FY2020 Jul 30, 2020 Read transcript
Company Conference Presentations Jun 8, 2020 Read transcript
Shareholder/Analyst Calls May 13, 2020 Read transcript
Q1 FY2020 May 5, 2020 Read transcript
Q4 FY2019 Feb 6, 2020 Read transcript